✦ LIBER ✦

Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?

✍ Scribed by Hilkens, C. M. U.; Isaacs, J. D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Developing tolerogenic dendritic cell th

✍ Stoop, J. N.; Robinson, J. H.; Hilkens, C. M. U. 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 405 KB

Generation and characterisation of thera

✍ Harry, R. A.; Anderson, A. E.; Isaacs, J. D.; Hilkens, C. M. U. 📂 Article 📅 2010 🏛 BMJ Publishing Group 🌐 English ⚖ 508 KB

Generation and characterisation of thera

✍ Harry, R. A.; Anderson, A. E.; Isaacs, J. D.; Hilkens, C. M. U. 📂 Article 📅 2010 🏛 BMJ Publishing Group 🌐 English ⚖ 508 KB

Current systemic therapies for psoriasis

✍ Paul S Yamauchi; Dalia Rizk; Tanya Kormeili; Rickie Patnaik; Nicholas J Lowe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 125 KB

GENE THERAPY FOR PROSTATE CANCER: WHERE

✍ STEINER, MITCHELL S.; GINGRICH, JEFFREY R. 📂 Article 📅 2000 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 357 KB

WHERE ARE WE NOW WITH ADJUVANT THERAPY F

✍ Pierre Chapuis; Les Bokey 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB